the wall street journal
China Evergrande Aims to Recover $6 Billion From Executives, Others
The Wall Street Journal • 1 YEAR AGO
China Evergrande Aims to Recover $6 Billion From Executives, Others
The Wall Street Journal • 1 YEAR AGO
Studies being used to decide whether the U.S. should authorize an ecstasy-based drug for traumatized patients missed serious side effects and were marked by bias.
The Wall Street Journal • 1 YEAR AGO